• Sensex76755.05-715.06(-0.92%)
  • Nifty23996.25-191.45(-0.79%)
  • USDINR96.25-0.26(-0.26%)
Online tarding Partner With Us
BSE Prices delayed by 5 minutes ! Prices as on   Jul 22, 2026   ABB India 7507.3 [ -0.35% ]ACC 1358.7 [ -2.15% ]Ambuja Cements 430.75 [ -2.30% ]Asian Paints 2693.05 [ 0.04% ]Axis Bank 1239.75 [ -1.44% ]Bajaj Auto 10999.3 [ 5.68% ]Bank of Baroda 245.75 [ -0.81% ]Bharti Airtel 1950.05 [ 0.08% ]Bharat Heavy 416.3 [ 0.70% ]Bharat Petroleum 314.5 [ -1.49% ]Britannia Industries 5489.95 [ 0.17% ]Cipla 1415.1 [ -1.22% ]Coal India 428.25 [ -0.67% ]Colgate Palm 2107.75 [ 0.73% ]Dabur India 426.5 [ 0.08% ]DLF 651.2 [ -3.33% ]Dr. Reddy's Lab. 1183 [ -1.95% ]GAIL (India) 173.1 [ -0.43% ]Grasim Industries 3166.1 [ -0.33% ]HCL Technologies 1237.25 [ -0.18% ]HDFC Bank 753.15 [ -1.09% ]Hero MotoCorp 4985.6 [ -0.91% ]Hindustan Unilever 2154.35 [ 0.58% ]Hindalco Industries 950.05 [ -0.14% ]ICICI Bank 1441.45 [ -1.47% ]Indian Hotels Co. 725.3 [ -1.00% ]IndusInd Bank 1069.9 [ 0.53% ]Infosys 1052.3 [ -1.97% ]ITC 280.8 [ -0.07% ]Jindal Steel 1044.75 [ 0.00% ]Kotak Mahindra Bank 381.2 [ -1.23% ]L&T 3816.85 [ -0.79% ]Lupin 2405.8 [ -4.32% ]Mahi. & Mahi 3174.65 [ -0.86% ]Maruti Suzuki India 13546.5 [ -0.34% ]MTNL 27.68 [ -1.32% ]Nestle India 1492.2 [ 2.70% ]NIIT 95.95 [ -3.37% ]NMDC 83.35 [ -0.66% ]NTPC 350.55 [ 0.59% ]ONGC 251.9 [ 0.50% ]Punj. NationlBak 110.75 [ -1.16% ]Power Grid Corpn. 289.35 [ 0.94% ]Reliance Industries 1288.85 [ -1.14% ]SBI 1025.35 [ -1.81% ]Vedanta 262.35 [ -0.91% ]Shipping Corpn. 268.7 [ -3.01% ]Sun Pharmaceutical 1942.95 [ -0.98% ]Tata Chemicals 691.4 [ 0.10% ]Tata Consumer 1095 [ 1.22% ]Tata Motors Passenge 327.8 [ -1.78% ]Tata Steel 186.5 [ -0.40% ]Tata Power Co. 378.6 [ -0.75% ]Tata Consult. Serv. 2208.85 [ -0.52% ]Tech Mahindra 1561.35 [ -0.93% ]UltraTech Cement 11892.9 [ -1.66% ]United Spirits 1404.6 [ 0.96% ]Wipro 174.45 [ -0.23% ]Zee Entertainment 105.6 [ -1.86% ]
BSE

MARKETS

News Details

( As on 21/07/2026 09:28)

Lupin spins Off Two Oncology Programs into Kaveri Therapeutics

Lupin Limited has announced the strategic spin-off of its two oncology drug candidates—LNP7457 (PRMT5) and LNP8701 (SOS1)—into Kaveri Therapeutics Inc., a US-based clinical-stage oncology company, to accelerate their global development.

Under the agreement, Lupin's wholly owned subsidiary Lupin Inc. will retain a significant equity stake in Kaveri, provide seed funding, and grant the company exclusive rights to develop the two programs. Kaveri will independently advance the candidates through global clinical trials.

Both oncology programs have shown encouraging clinical results, with LNP7457 and LNP8701 reporting positive data at the ASCO 2025 and ASCO 2026 meetings, respectively. The move aligns with Lupin's strategy to accelerate the development of innovative targeted cancer therapies while retaining long-term value through its stake in Kaveri.